Impaired activation of the MEK-ERK, AKT, and mTOR signalling pathways due to mutant FGFR1 membrane expression can lead to compromised cellular functions, contributing to the pathogenesis of CHH. This evidence concerns the gene MAP2K7 and cartilage-hair hypoplasia.